
Neuralink's secondary market valuation surged to $42B, up from $9B last year, as investors scramble for Musk's brain-chip startup. Some bids top $60B. 21 patients implanted so far.
Neuralink, Elon Musk's brain-chip startup, is being valued at as much as $42 billion in secondary market transactions, according to correspondence seen by Business Insider and a person familiar with the matter.
That is nearly five times the $9 billion valuation from its last funding round in 2024, Semafor reported at the time. Transactions in recent months have ranged from $29 billion to $42 billion, with some bidders seeking shares at nearly $60 billion, according to Caplight, a private markets research provider.
Because Neuralink is private, shares trade on secondary markets where employees and early investors sell stakes. These valuations reflect demand rather than a public market price. Not all investors agree on the price. Some have balked at the high valuations, the person familiar said.
Neuralink builds brain implants to help paralyzed people control computers and eventually restore eyesight. So far, the chips have been implanted in 21 trial patients, the company said earlier this year.
Musk has a track record of creating value for private investors. Investors in X and XAI were able to obtain shares in SpaceX through those acquisitions, one venture investor said. That track record has fueled demand for Neuralink shares.
Neuralink's official valuation and any new funding round remain unclear. In May, the sovereign wealth fund of Oman disclosed an investment at an undisclosed valuation. SpaceX, Musk's rocket company, went public last month and is now valued at about $1.6 trillion in public markets.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.